At Ypsomed we pursue a long-term corporate sustainability strategy and are committed to acting responsibly towards our employees, our partners, society and the environment.
The increasing adoption of pre-filled self-injection systems provides convenience and safety for patients, but also increases the use of plastics and its impact on the environment. Ypsomed is acting now and has fully integrated responsibility & engagement as one of the key pillars of its corporate strategy. Our commitment to sustainability takes many forms, from the NetZero Program, our roadmap to net zero emissions by 2040, to our ecodesign principles, embedding eco-friendly practices into product design. Looking further forward, our next generation of platform products will represent a paradigm shift in responsible, sustainable self-injection device manufacturing.
Learn more about Sustainability at Ypsomed and our corporate NetZero Program.
The NetZero Program: Advancing towards Net Zero carbon emission selfcare solutions
Join us as we drive a sustainable, efficient, and responsible medical technology industry. The NetZero Program is Ypsomed's ambitious greenhouse gas emissions reduction roadmap, aiming for net zero emissions by 2040 along the entire value chain. We commit ourselves to the science-based emissions reduction targets according to the Science Based Targets initiative, SBTi.
Partnering with Ypsomed unveils forward-thinking solutions, laying the groundwork for a future of net zero emissions
Scope 1+2
2030
Net zero operational carbon emissions.
Scope 1-3
2030
A selection of products meet net zero carbon emissions across their individual value chain.
Scope 1-3
2040
Net zero carbon emissions across the entire value chain.
The NetZero Program leads the way for carbon-reduced products
Ypsomed offers customers a widening range of sustainable choices. Life Cycle Assessments identify and optimize areas for CO2 reduction (cradle-to-gate). The improvements include bio-based, chemically identical materials which are biocompatible and provide significant CO2 reduction, as well as advanced packaging made from recycled materials. The products available in the NetZero Program currently achieve between 20 % and 50 % CO2 reduction by optimising the product and packaging. Further savings are currently under review. External ISCC+ certification ensures sustainable material traceability along the entire supply chain.
The net zero journey of Ypsomed continues step by step, providing options to match your sustainability goals as part of our reduction roadmap.
Carbon-reduced materials
Take the initial step to reduce the CO2 emissions of your drug-device combination product.
Manufacturing materials and in particular plastics make up the largest proportion of our CO2 footprint. The NetZero Program facilitates measurable CO2 reduction for your device based on the following measures:
- Use of ISCC+ certified bio-based plastics in the mass balance approach for device carbon reduction
- Device transport trays made from recycled materials reduce the CO2 footprint for each device
- Biocompatibility, functionality and safety are maintained so that no additional testing is required
- CO2 reduction declaration for the use of ISCC+ certified bio-based plastic materials
Contribution to global climate action
Taking our commitment further, we offer you our contribution to high quality offset projects.
To achieve our ambitious climate targets, we must first and foremost substantially reduce GHG emissions across the value chain. Nonetheless, we cannot avoid GHG emissions altogether and will continue to rely on offsetting a portion of our remaining emissions to achieve net-zero. Ypsomed supports high-quality global climate projects for CO2-reduced products that are part of the NetZero programme to the extent of the remaining greenhouse gas emissions (cradle-to-gate):
- Quality verified: Externally supported climate protection meets certified standards (Gold standard, Verra VCS-CCB)
- Sustainability added value: Projects support various Sustainable Development Goals (SDGs)
- Diversification: Support both avoiding further emissions (so-called avoidance projects) as well as removing them from the atmosphere and storing them permanently (removal projects)
The number of product platforms available in the NetZero Program is increasing, maintaining biocompatibility, functionality and safety, with no additional testing required.
Downloads
Download LCA factsheet & ecodesign guidelines to learn more.
Ecodesign principles for new products
We continuously optimize the entire life cycle of our products and the entire value chain – from development, procurement and production to packaging, product use, as well as disposal and recycling. Since 2021, we adhere to ecodesign principles for the development of new products, ensuring that environmental considerations are integrated into every stage of product development. From design with a minimum number of parts to selecting sustainable materials and optimizing recyclability, our commitment to eco-friendly practices is embedded in the design of new products, striving for minimal environmental impact throughout the product life cycle, without compromising quality or functionality.
Significant levers for CO2 reduction lie in alternative material sourcing for devices and packaging as well as in ecodesign principles
Making sustainability measurable – How we calculate the product carbon footprint at Ypsomed
At Ypsomed, we calculate the Product Carbon Footprint (PCF) of our medical devices using a cradle-to-gate approach including end-of-life. This means we account for all relevant greenhouse gas emissions, from raw material extraction and production to disposal – excluding the use phase. Our calculations are based on internationally recognized standards such as ISO 14040/44 and ISO 14067.
We have already calculated the PCF for all our platforms, each verified through an external review by independent experts. These footprints are updated at least every two years to reflect the latest data, processes, and improvements, providing a reliable foundation for our sustainability decisions.
Looking ahead, we plan to expand our assessments further: In addition to greenhouse gas emissions, we aim to include other environmental impacts such as acidification, eutrophication, and resource depletion, all as part of a comprehensive Life Cycle Assessments (LCA).
Detailed information on our methodology and system boundaries can be found in our LCA Factsheet.
Driving partnerships for global climate action
As a founding member, Ypsomed is instrumental in the Alliance to Zero, a non-profit association for pharma and biotech supply chain companies. Our vision is to facilitate the transition of the pharma sector to compliance with net zero emissions in line with the goal of the Paris climate agreement.
Our Sustainability Academy is a center for sustainability training and sensitization, bridging internal and external stakeholders. Here, we exchange ideas on sustainability practices and network with a broad spectrum of experts, enhancing our environmental initiatives.
Embracing the principle of reduction before compensation, Ypsomed prioritizes CO2 reduction while also engaging in global climate action projects to reduce greenhouse gas emissions around the globe. To this end, we focus on high-quality projects that are verified by internationally recognized and certified standards and that demonstrably contribute to a set of Sustainable Development Goals (SDGs). With the financial contribution to high-quality greenhouse gas reduction projects, we promote the global reduction of emissions, over and above our own reduction measures.
Learn more about Sustainability as part of Ypsomed's corporate strategy.
Reduce CO2 emissions NOW and advance towards a sustainable future. Contact us to partner for impactful environmental action:
